| The effect of glia-glia interactions on oligodendrocyte precursor cell biology during development and in demyelinating diseases D Clemente, MC Ortega, C Melero-Jerez, F De Castro Frontiers in cellular neuroscience 7, 268, 2013 | 146 | 2013 |
| Myeloid‐derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis V Moliné‐Velázquez, H Cuervo, V Vila‐del Sol, MC Ortega, D Clemente, ... Brain Pathology 21 (6), 678-691, 2011 | 125 | 2011 |
| FGF-2 and Anosmin-1 are selectively expressed in different types of multiple sclerosis lesions D Clemente, MC Ortega, FJ Arenzana, F de Castro Journal of Neuroscience 31 (42), 14899-14909, 2011 | 120 | 2011 |
| RhoB controls endothelial barrier recovery by inhibiting Rac1 trafficking to the cell border. MJ Marcos-Ramiro B, García-Weber D, Barroso S, Feito J, Ortega MC, Cernuda ... J Cell Biology 213 (3), 385-402, 2016 | 78 | 2016 |
| Regulation of oligodendrocyte precursor migration during development, in adulthood and in pathology F de Castro, A Bribián, MC Ortega Cellular and molecular life sciences 70, 4355-4368, 2013 | 74 | 2013 |
| Neuregulin-1/ErbB4 signaling controls the migration of oligodendrocyte precursor cells during development MC Ortega, A Bribián, S Peregrín, MT Gil, O Marín, F de Castro Experimental neurology 235 (2), 610-620, 2012 | 61 | 2012 |
| Megalin mediates the influence of sonic hedgehog on oligodendrocyte precursor cell migration and proliferation during development MC Ortega, O Cases, P Merchán, R Kozyraki, D Clemente, F de Castro Glia 60 (6), 851-866, 2012 | 58 | 2012 |
| Neuroendothelial NMDA receptors as therapeutic targets in experimental autoimmune encephalomyelitis R Macrez, MC Ortega, I Bardou, A Mehra, A Fournier, SMA Van der Pol, ... Brain 139 (9), 2406-2419, 2016 | 49 | 2016 |
| Myeloid derived suppressor cells in inflammatory conditions of the central nervous system C Melero-Jerez, MC Ortega, V Moline-Velazquez, D Clemente Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1862 (3), 368-380, 2016 | 46 | 2016 |
| TLR4 pathway impairs synaptic number and cerebrovascular functions through astrocyte activation following traumatic brain injury JM Rosa, V Farré‐Alins, MC Ortega, M Navarrete, AB Lopez‐Rodriguez, ... British journal of pharmacology 178 (17), 3395-3413, 2021 | 40 | 2021 |
| Regulatory cells in multiple sclerosis: From blood to brain L Calahorra, C Camacho-Toledano, MP Serrano-Regal, MC Ortega, ... Biomedicines 10 (2), 335, 2022 | 32 | 2022 |
| The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability V Moliné-Velázquez, MC Ortega, VV del Sol, C Melero-Jerez, F de Castro, ... Neurobiology of disease 67, 149-164, 2014 | 32 | 2014 |
| Myeloid‐derived suppressor cells support remyelination in a murine model of multiple sclerosis by promoting oligodendrocyte precursor cell survival, proliferation, and … C Melero‐Jerez, B Fernández‐Gómez, R Lebrón‐Galán, MC Ortega, ... Glia 69 (4), 905-924, 2021 | 25 | 2021 |
| Activation of Rac1 and RhoA preserve corneal endothelial barrier function MC Ortega, D Santander-García, B Marcos-Ramiro, S Barroso, S Cox, ... Investigative Ophthalmology & Visual Science 57 (14), 6210-6222, 2016 | 12 | 2016 |
| Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis C Camacho-Toledano, I Machín-Díaz, L Calahorra, M Cabañas-Cotillas, ... Journal of neuroinflammation 19 (1), 277, 2022 | 8 | 2022 |
| Tissue plasminogen activator worsens experimental autoimmune encephalomyelitis by complementary actions on lymphoid and myeloid cell responses P Hélie, C Camacho-Toledano, L Lesec, C Seillier, AJ Miralles, ... Journal of neuroinflammation 18, 1-17, 2021 | 7 | 2021 |
| A human cellular system for analyzing signaling during corneal endothelial barrier dysfunction D Santander-García, MC Ortega, S Benito-Martínez, S Barroso, ... Experimental Eye Research 153, 8-13, 2016 | 4 | 2016 |
| Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis MC Ortega, R Lebrón-Galán, I Machín-Díaz, M Naughton, I Pérez-Molina, ... Acta Neuropathologica 146 (2), 263-282, 2023 | 3 | 2023 |
| El receptor megalina y la esclerosis múltiple MCO Muñoz, D Clemente, F de Castro Soubriet Mente y cerebro, 55-56, 2015 | | 2015 |
